In September 2017 the Short Life Working Group (SLWG) was established. The purpose of this group was to advise on the scope of a programme to improve safety in the use of medicines, including how to reduce medication errors and establish the best way to measure progress. The objectives of the group were to:
- In the context of the WHO Global Patient Safety Challenge Medication Without Harm, advise on the overall strategy and programme required to drive improvement in medicines safety, drawing on work underway across NHS England, NHS Improvement, the Care Quality Commission (CQC), the Medicines and Healthcare products Regulatory Agency (MHRA) and in the NHS and academia.
- Identify those areas in which efforts need to be targeted in the short, medium and long-term.
- Provide clinical and academic expertise and advice on the current barriers and issues in medicines safety, and how these can be overcome.
- Advise on the best ways to measure medication errors and medication safety.
This report outlines the main areas of discussion by the group, and although it is not all-encompassing, the report highlights key recommendations for improvement in medicines safety.
The report of the Short Life Working Group on reducing medication-related harm (February 2018) https://www.gov.uk/government/publications/medication-errors-short-life-working-group-report
0 reactions so far
There are no comments to display.
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!Register a new account
Already have an account? Sign in here.Sign In Now